* Index of all generic, trade, and alternate drug names
* Chemical and therapeutic classes, FDA pregnancy risk category, and controlled substance schedule
* Indications and dosages, as well as route, onset, peak, and duration information
* Incompatibilities and contraindications
* Interactions with drugs, food, and activities
* Adverse reactions
* Nursing considerations, including key teaching points for patients
* Mechanism-of-action illustrations
* Warnings and precautions New drug entries include alirocumab, brexpiprazole, cangrelor, cariprazine, edoxaban, eluxadoline, evolocumab, flibanserin, idarucizumab, ivabradine, and mepolizumab. Updates to the appendices include parenteral insulin preparations, selected ophthalmic drugs, selected topical drugs, selected antivirals, selected antineoplastic drugs, and interferons.
Share This Book: